文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

老年谵妄:诊断与治疗进展

Delirium in Older Persons: Advances in Diagnosis and Treatment.
PubMed 文献 · JAMA · 2017-01-01
一句话结论非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素可有效预防谵妄,并推荐用于谵妄治疗;抗精神病药等镇静药仅保留用于严重躁动危及安全或中断必要治疗时。

本文为综述,检索2011年1月1日至2017年3月16日Ovid MEDLINE、Embase和Cochrane Library,聚焦老年人群,排除仅基于ICU的研究和非英文文献。共纳入127篇文献(25项临床试验、42项队列研究、5项系统评价和Meta分析、55篇其他类型),治疗研究共代表11616例患者。诊断进展包括3分钟诊断评估、4A测试、家属谵妄评估法等简短筛查工具,以及谵妄评估法-严重程度评分用于监测治疗反应和风险分层。非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素可有效预防谵妄,也推荐用于谵妄治疗;当前建议将抗精神病药和其他镇静药物保留用于治疗严重躁动,即对患者或工作人员安全构成风险或威胁中断必要医疗操作时。

要点

  • 非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素,可有效预防谵妄,也推荐用于谵妄治疗。
  • 当前建议将抗精神病药和其他镇静药物保留用于治疗严重躁动,即对患者或工作人员安全构成风险或威胁中断必要医疗操作时。
  • 简短筛查工具如3分钟诊断评估、4A测试、家属谵妄评估法(基于代理人的测量)具有高敏感性和特异性,可用于诊断。
  • 谵妄评估法-严重程度评分等严重程度测量有助于监测治疗反应、风险分层和评估预后。
  • 药物预防和治疗谵妄仍存在争议;诊断进展可改善谵妄的识别和风险分层。

适用人群与场景

  • 老年患者;检索聚焦老年人群研究,排除仅基于ICU的研究和非英文文献。

诊断标准与关键阈值

  • 谵妄定义为急性注意力与认知障碍。
  • 简短筛查工具包括3分钟诊断评估、4A测试、家属谵妄评估法(基于代理人的测量),具有高敏感性和特异性。
  • 谵妄评估法-严重程度评分可用于监测治疗反应、风险分层和评估预后。

处置流程与药物剂量

  • 非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素,用于谵妄预防和谵妄治疗。
  • 当前建议将抗精神病药和其他镇静药物保留用于治疗严重躁动,即对患者或工作人员安全构成风险或威胁中断必要医疗操作时。

研究设计与关键结果

  • 综述检索2011年1月1日至2017年3月16日Ovid MEDLINE、Embase和Cochrane Library,共纳入127篇文献:25项临床试验、42项队列研究、5项系统评价和Meta分析、55篇其他类型。
  • 治疗研究共代表11616例患者。
  • 诊断进展包括3分钟诊断评估、4A测试、家属谵妄评估法等简短筛查工具,以及谵妄评估法-严重程度评分用于监测治疗反应、风险分层和评估预后。
  • 非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素,可有效预防谵妄,也推荐用于谵妄治疗。
  • 当前建议将抗精神病药和其他镇静药物保留用于治疗严重躁动,即对患者或工作人员安全构成风险或威胁中断必要医疗操作时。
  • 药物预防和治疗谵妄仍存在争议。

证据类型、等级与局限

  • 证据类型:综述,检索Ovid MEDLINE、Embase和Cochrane Library,纳入127篇文献(25项临床试验、42项队列研究、5项系统评价和Meta分析、55篇其他类型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对老年患者可使用3分钟诊断评估、4A测试、家属谵妄评估法等简短筛查工具提高谵妄识别,并用谵妄评估法-严重程度评分监测治疗反应和风险分层。
  • 非药物干预针对制动、功能下降、视听障碍、脱水、睡眠剥夺等危险因素用于谵妄预防和治疗。
  • 当前建议抗精神病药和其他镇静药物仅保留用于严重躁动,即对患者或工作人员安全构成风险或威胁中断必要医疗操作时。
  • 药物预防和治疗谵妄仍存在争议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Delirium is defined as an acute disorder of attention and cognition. It is a common, serious, and often fatal condition among older patients. Although often underrecognized, delirium has serious adverse effects on the individual's function and quality of life, as well as broad societal effects with substantial health care costs.

OBJECTIVE: To summarize the current state of the art in diagnosis and treatment of delirium and to highlight critical areas for future research to advance the field.

EVIDENCE REVIEW: Search of Ovid MEDLINE, Embase, and the Cochrane Library for the past 6 years, from January 1, 2011, until March 16, 2017, using a combination of controlled vocabulary and keyword terms. Since delirium is more prevalent in older adults, the focus was on studies in elderly populations; studies based solely in the intensive care unit (ICU) and non-English-language articles were excluded.

FINDINGS: Of 127 articles included, 25 were clinical trials, 42 cohort studies, 5 systematic reviews and meta-analyses, and 55 were other categories. A total of 11 616 patients were represented in the treatment studies. Advances in diagnosis have included the development of brief screening tools with high sensitivity and specificity, such as the 3-Minute Diagnostic Assessment; 4 A's Test; and proxy-based measures such as the Family Confusion Assessment Method. Measures of severity, such as the Confusion Assessment Method-Severity Score, can aid in monitoring response to treatment, risk stratification, and assessing prognosis. Nonpharmacologic approaches focused on risk factors such as immobility, functional decline, visual or hearing impairment, dehydration, and sleep deprivation are effective for delirium prevention and also are recommended for delirium treatment. Current recommendations for pharmacologic treatment of delirium, based on recent reviews of the evidence, recommend reserving use of antipsychotics and other sedating medications for treatment of severe agitation that poses risk to patient or staff safety or threatens interruption of essential medical therapies.

CONCLUSIONS AND RELEVANCE: Advances in diagnosis can improve recognition and risk stratification of delirium. Prevention of delirium using nonpharmacologic approaches is documented to be effective, while pharmacologic prevention and treatment of delirium remains controversial.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Oh ES, Fong TG, Hshieh TT, et al. Delirium in Older Persons: Advances in Diagnosis and Treatment. JAMA. 2017. PMID: 28973626. doi:10.1001/jama.2017.12067

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。